Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 20/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 5/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 3/20 | 1.00 |
| ▸ | ACACA | Q13085 | 7/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1619864 | 0.90 | ACACB (1.00) | ACACBCYP2C9CYP2C19ACACA | |
| SCHEMBL1619861 | 0.90 | ACACB (1.00) | ACACBCYP2C9CYP2C19ACACA | |
| SCHEMBL1619741 | 0.81 | ACACB (0.69) | ACACBCYP2C9CYP2C19ACACA | |
| SCHEMBL1619743 | 0.81 | ACACB (0.69) | ACACBCYP2C9CYP2C19ACACA | |
| SCHEMBL1620134 | 0.81 | ACACB (0.72) | ACACBCYP2C9CYP2C19ACACA | |
| SCHEMBL1620131 | 0.81 | ACACB (0.72) | ACACBCYP2C9CYP2C19ACACA | |
| SCHEMBL1619812 | 0.79 | ACACB (0.70) | ACACBCYP2C9CYP2C19ACACA | |
| SCHEMBL1619805 | 0.79 | ACACB (0.70) | ACACBCYP2C9CYP2C19ACACA | |
| SCHEMBL17050685 | 0.79 | ACACB (0.66) | ACACBCYP2C9CYP2C19ACACA | |
| SCHEMBL17050516 | 0.78 | ACACB (1.00) | ACACBCYP2C9CYP2C19ACACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150246938-A1 | NOVEL OLEFIN DERIVATIVE | SHIONOGI & CO., LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
| US-20150246938-A1 | NOVEL OLEFIN DERIVATIVE | SHIONOGI & CO., LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246938-A1 | NOVEL OLEFIN DERIVATIVE | ACSS2, ACACB, ACAT2 | ACACB 2/4885CYP2C9 524/4885CYP2C19 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.